Craig Dorrell

Title: Craig Dorrell: Innovator in Monoclonal Antibodies

Introduction

Craig Dorrell is a prominent inventor based in Portland, OR (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 3 patents, his work has the potential to impact medical diagnostics and treatment.

Latest Patents

Dorrell's latest patents focus on isolated monoclonal antibodies that specifically bind to cell surface antigens expressed on human pancreatic endocrine and exocrine cells. These antibodies can be utilized to detect and isolate pancreatic cells, which is crucial for diagnosing conditions such as diabetes and pancreatic tumors. The patents also describe methods for treating pancreatic tumors using these antibodies, which can be conjugated to effector molecules or detectable markers.

Career Highlights

Craig Dorrell is affiliated with Oregon Health & Science University, where he conducts research and develops innovative solutions in the field of medicine. His work has garnered attention for its potential applications in treating pancreatic diseases and improving patient outcomes.

Collaborations

Dorrell has collaborated with notable colleagues, including Markus Grompe and Philip R. Streeter, to advance research in monoclonal antibodies and their therapeutic uses.

Conclusion

Craig Dorrell's contributions to the field of monoclonal antibodies exemplify the importance of innovation in medical research. His patents and ongoing work continue to pave the way for advancements in the diagnosis and treatment of pancreatic conditions.